|
MSFT
|
Technology |
BMO Capital |
Maintains
|
Market Perform
→
Perform
|
—
|
$3.1T
|
$27.11
|
+0.0%
|
-1.1%
|
+1.1%
|
+1.7%
|
-0.9%
|
+1.4%
|
|
MSFT
|
Technology |
SunTrust Robinson Humphrey |
Maintains
|
Neutral
→
Neutral
|
—
|
$3.1T
|
$27.11
|
+0.0%
|
-1.1%
|
+1.1%
|
+1.7%
|
-0.9%
|
+1.4%
|
|
MU
|
Technology |
Drexel Hamilton |
Upgrade
|
Hold
→
Buy
|
—
|
$786.1B
|
$6.66
|
+1.2%
|
+2.9%
|
-3.5%
|
+1.4%
|
+1.8%
|
-0.4%
|
|
ASML
|
Technology |
Pacific Crest |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$602.8B
|
$62.70
|
-0.4%
|
+1.5%
|
-0.1%
|
+0.7%
|
+0.2%
|
+0.8%
|
|
ASML
|
Technology |
Caris & Co. |
Downgrade
|
Buy
→
Average
|
—
|
$602.8B
|
$62.70
|
-0.4%
|
+1.5%
|
-0.1%
|
+0.7%
|
+0.2%
|
+0.8%
|
|
ORCL
|
Technology |
Janney Capital |
Maintains
|
Buy
→
Buy
|
—
|
$520.1B
|
$31.61
|
-0.2%
|
+1.1%
|
+1.1%
|
+1.7%
|
+3.7%
|
-0.4%
|
|
SAP
|
Technology |
Janney Capital |
Maintains
|
Buy
→
Buy
|
—
|
$210.1B
|
$78.91
|
+0.6%
|
+1.9%
|
+0.3%
|
+0.7%
|
-0.9%
|
+0.7%
|
|
NEE
|
Utilities |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$188.1B
|
$17.51
|
-0.5%
|
-0.8%
|
+1.5%
|
+0.5%
|
-0.5%
|
+0.1%
|
|
NEE
|
Utilities |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$188.1B
|
$17.51
|
-0.5%
|
-0.8%
|
+1.5%
|
+0.5%
|
-0.5%
|
+0.1%
|
|
CRM
|
Technology |
Longbow Research |
Maintains
|
Neutral
→
Neutral
|
—
|
$171.5B
|
$41.66
|
-0.8%
|
+0.1%
|
+1.3%
|
+1.2%
|
-0.6%
|
+0.1%
|
|
GILD
|
Healthcare |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$163.8B
|
$37.39
|
-0.1%
|
-0.7%
|
+1.6%
|
+0.5%
|
-1.4%
|
-1.5%
|
|
AZN
|
Healthcare |
Societe Generale |
Downgrade
|
Hold
→
Sell
|
—
|
$146.4B
|
$48.34
|
-2.9%
|
-1.8%
|
-0.7%
|
+1.8%
|
-1.0%
|
+1.0%
|
|
CVS
|
Healthcare |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
CVS
|
Healthcare |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
CVS
|
Healthcare |
MacquarieC |
Upgrade
|
Neutral
→
Outperform
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
CVS
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
CVS
|
Healthcare |
Cantor Fitzgerald |
Maintains
|
Buy
→
Buy
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
CVS
|
Healthcare |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$119.7B
|
$48.50
|
+1.0%
|
+1.5%
|
-0.4%
|
+0.3%
|
-0.9%
|
+0.8%
|
|
BP
|
Energy |
Credit Suisse |
Downgrade
|
Outperform
→
Neutral
|
—
|
$119.7B
|
$41.47
|
-0.7%
|
-0.2%
|
+0.8%
|
+0.7%
|
+0.2%
|
+0.3%
|
|
CME
|
Financial Services |
Keefe Bruyette & Woods |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$108.9B
|
$51.21
|
-0.8%
|
+0.0%
|
+0.7%
|
+1.6%
|
+0.4%
|
-2.3%
|